Stryker (NYSE:SYK) Releases FY 2025 Earnings Guidance

Key Points

• Stryker has provided FY 2025 earnings guidance with an expected earnings per share range of $13.400-$13.600, slightly above the consensus estimate of $13.345.
• The stock traded down by $7.04 to $393.37, with a market cap of $150.14 billion and a price-to-earnings ratio of 53.16.
• Stryker recently announced a quarterly dividend of $0.84 per share, representing an annualized dividend of $3.36 and a yield of 0.9%.

Stryker (NYSE:SYK - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 13.400-13.600 for the period, compared to the consensus earnings per share estimate of 13.345. The company issued revenue guidance of -.

Stryker Price Performance

Shares of NYSE:SYK traded down $7.04 during trading on Thursday, hitting $393.37. 2,292,491 shares of the company's stock were exchanged, compared to its average volume of 1,436,037. The company has a market cap of $150.14 billion, a price-to-earnings ratio of 53.16, a PEG ratio of 2.97 and a beta of 0.91. Stryker has a 52-week low of $314.93 and a 52-week high of $406.19. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. The business's 50-day simple moving average is $387.13 and its 200 day simple moving average is $379.97.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.06 by $0.07. Stryker had a return on equity of 23.74% and a net margin of 12.31%. As a group, equities analysts predict that Stryker will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. Stryker's payout ratio is 45.41%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SYK. JMP Securities reissued a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. BTIG Research reissued a "buy" rating on shares of Stryker in a research note on Monday, July 14th. Truist Financial raised their price target on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research note on Monday, May 5th. Roth Mkm lifted their target price on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research report on Friday, May 2nd. Finally, Sanford C. Bernstein set a $450.00 target price on Stryker in a research report on Monday, May 5th. Four analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $428.55.

Insider Activity

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 5.90% of the company's stock.

Institutional Investors Weigh In On Stryker

A hedge fund recently raised its stake in Stryker stock. Brighton Jones LLC lifted its stake in Stryker Corporation (NYSE:SYK - Free Report) by 15.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,564 shares of the medical technology company's stock after buying an additional 609 shares during the quarter. Brighton Jones LLC's holdings in Stryker were worth $1,643,000 as of its most recent SEC filing. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.